#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia recurrent Short-bowel syndrome Phenylketonuria Breast cancer Craniocerebral injury Extranodal marginal zone B-cell lymphoma (MALT type) Cholestatic pruritus B-cell lymphoma recurrent IPEX syndrome Dilated cardiomyopathy Pleural mesothelioma Laryngeal squamous cell carcinoma Hepatitis D Transplant rejection Acute respiratory distress syndrome More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Basic Information Angiosarcoma metastatic – Trials in Disease Usher’s syndrome Gastrointestinal stromal tumour – Diagnostics Piriformis syndrome – Basic Information Glomerulonephritis rapidly progressive – Trials in Disease Haemophilia B with anti factor IX – Basic Information Methylmalonic acidaemia – Diagnostics Synovial sarcoma – Life with Disease Mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Oxybate Betula Pollen Extract Dostarlimab Glycopyrronium Bromide SGN-ALPV Itepekimab Cipaglucosidase Alfa Sapropterin Dihydrochloride Isaralgagene Civaparvovec Dextrose Bp Mk-1942 Dexchlorpheniramine Maleate Bi-1808 Lansoprazole Nemvaleukin Alfa Syn321 Lomustine Benzylpenicillin Sodium Soya-Bean Oil Refined L-Glutamic Acid More therapies…

    Learn about Your Condition

    Arteriovenous graft thrombosis Polymyalgia rheumatica Pain Antithrombin III deficiency Indolent systemic mastocytosis Porphyria non-acute Transplantation complication Breast neoplasm Cerebrovascular accident Laryngeal cancer stage III CADASIL Neuropathic arthropathy Chorioretinitis Pustular psoriasis Haemodialysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Tolerability of Sotatercept for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Sotatercept
    Czechia France Hungary Italy The Netherlands Poland +1

  • Study on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Remibrutinib
    • SALICYLIC ACID
    Austria Belgium Czechia France Germany Greece +4

  • Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Drugs:
    • Envudeucitinib
    Austria Belgium Bulgaria Czechia Estonia France +7

  • Study on Sotatercept for Treating Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Sotatercept
    Belgium France Germany Italy Poland Spain +1

  • Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Ro7790121
    France Germany Italy Poland Spain

  • Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • HEMOPEXIN, HUMAN
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Envudeucitinib
    • Apremilast
    Austria Estonia France Germany Hungary Latvia +3

  • Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Belgium Denmark France Germany Greece Italy +2

  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sonelokimab
    • Risankizumab
    Bulgaria Czechia France Germany Hungary Poland +1

  • Long-Term Study on Oxytocin for Children with Prader-Willi Syndrome Up to Age 4

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Oxytocin
    France
Previous Page
1 … 28 29 30 31 32 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!